on Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health Launches 2025 Salix GI Health Scholars Program
Bausch Health Companies Inc., along with Salix Pharmaceuticals, has opened applications for the 2025 Salix Gastrointestinal Health Scholars Program. The initiative aims to support ten students living with gastrointestinal (GI) diseases, providing scholarships up to $10,000. This effort is part of their commitment to aid students who excel academically while managing their GI conditions.
Eligible students can apply by submitting essays detailing their personal challenges and experiences with GI diseases. Scholarships are available for those attending two- or four-year colleges, universities, or advanced vocational/technical schools in the 2025-2026 academic year. The program includes categories for undergraduates, graduates, and single or working parents.
Applications are due by May 5, 2025, with winners to be announced in the summer. Additional details and requirements are available on the Salix website.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bausch Health Companies Inc. news